LENZ — LENZ Therapeutics, Inc.

LENZLENZ Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · lenz-tx.com

7.795USD+3.25%Mkt Cap: 245.50M USDP/E: —Last update: 2026-05-26

LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and L…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap245.50M USD

Enterprise Value-21.93M USD

Revenue (TTM)20.99M USD

Gross Profit18.67M USD

Net Income (TTM)-82.13M USD

Revenue/Share0.7050 USD

Last Price7.795 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees152

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-2.17

PEG—

EV/EBITDA0.19

EV/Revenue-1.04

P/S11.23

P/B0.83

EPS (TTM)-3.64

EPS (Forward)-3.47

52W Range

6.6103% of range50.40

52W High50.40 USD

52W Low6.610 USD

Profitability

Gross Margin97.81%

Oper. Margin-2321.67%

EBITDA Margin0.00%

Profit Margin-430.25%

ROE-28.88%

ROA-26.85%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-69.17M USD

CapEx (TTM)827.00K USD

FCF Margin-232.57%

FCF Yield-19.88%

Net Debt-257.71M USD

Net Debt/EBITDA2.18

Balance Sheet

Debt/Equity0.00

Current Ratio10.40

Quick Ratio10.11

Book Value/Sh9.071 USD

Cash/Share8.241 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateMar 21, 2024

Splits

Last Split1:7

Split DateMar 22, 2024

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)32.00 USD

Target Range—

# Analysts—

Ownership

Shares Out.31.35M

Float18.48M

Insiders2.65%

Institutions107.90%

Short Interest

Short Ratio13.3d

Short % Float56.33%

Short % Out.34.20%

Shares Short10.72M

Short (prev mo.)9.03M

Technical

SMA 509.440 (-17.4%)

SMA 20022.97 (-66.1%)

Beta1.67

S&P 52W Chg28.31%

Avg Vol (30d)858.73K

Avg Vol (10d)1.02M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—